CH619240A5 - - Google Patents

Download PDF

Info

Publication number
CH619240A5
CH619240A5 CH1332375A CH1332375A CH619240A5 CH 619240 A5 CH619240 A5 CH 619240A5 CH 1332375 A CH1332375 A CH 1332375A CH 1332375 A CH1332375 A CH 1332375A CH 619240 A5 CH619240 A5 CH 619240A5
Authority
CH
Switzerland
Prior art keywords
acid
radical
compounds
formula
ether
Prior art date
Application number
CH1332375A
Other languages
German (de)
English (en)
Inventor
Hans Dr Petzoldt
Hans-Joerg Dr Vidic
Klaus Dr Prezewowsky
Yukishige Dr Nishino
Rudolf Prof Dr Wiechert
Henry Dr Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449327A external-priority patent/DE2449327C2/de
Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH619240A5 publication Critical patent/CH619240A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/912—Absidia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH1332375A 1974-10-14 1975-10-14 CH619240A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449327A DE2449327C2 (de) 1974-10-14 1974-10-14 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de) 1975-08-08 1975-08-08 7-hydroxy-oestradiole

Publications (1)

Publication Number Publication Date
CH619240A5 true CH619240A5 (xx) 1980-09-15

Family

ID=25767825

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1332375A CH619240A5 (xx) 1974-10-14 1975-10-14
CH977879A CH619268A5 (xx) 1974-10-14 1979-10-31

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH977879A CH619268A5 (xx) 1974-10-14 1979-10-31

Country Status (23)

Country Link
US (1) US4011314A (xx)
JP (1) JPS5165747A (xx)
AT (1) AT348695B (xx)
CA (1) CA1054143A (xx)
CH (2) CH619240A5 (xx)
CS (2) CS205009B2 (xx)
DD (1) DD125588A5 (xx)
DK (1) DK135378C (xx)
ES (1) ES441784A1 (xx)
FI (1) FI54603C (xx)
FR (1) FR2287908A1 (xx)
GB (1) GB1528796A (xx)
HU (1) HU176715B (xx)
IE (1) IE42167B1 (xx)
IL (1) IL48276A (xx)
NL (1) NL7512041A (xx)
NO (1) NO140824C (xx)
NZ (1) NZ178886A (xx)
PH (1) PH13802A (xx)
PL (2) PL101461B1 (xx)
SE (1) SE405254B (xx)
SU (2) SU676170A3 (xx)
YU (2) YU243975A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
JP2000511404A (ja) 1996-04-09 2000-09-05 ビー・テイー・ジー・インターナシヨナル・リミテツド 神経精神、免疫又は内分泌障害を治療するための７α置換ステロイドの使用
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
PT1624878E (pt) * 2003-05-22 2007-01-31 Pantarhei Bioscience Bv Utilização de composições que compreendem um componente estrogénico para o tratamento e prevenção da dor musculoesquelética
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115444A (en) * 1962-01-22 1963-12-24 Olin Mathieson Process for microbial hydroxylation of steroids containing aromatic alpha-rings

Also Published As

Publication number Publication date
AT348695B (de) 1979-02-26
AU8571075A (en) 1977-04-21
CS205009B2 (en) 1981-04-30
IE42167B1 (en) 1980-06-18
HU176715B (en) 1981-04-28
SU676170A3 (ru) 1979-07-25
NZ178886A (en) 1978-04-28
IL48276A (en) 1979-03-12
PH13802A (en) 1980-10-01
PL103989B1 (pl) 1979-07-31
PL101461B1 (pl) 1978-12-30
DK135378B (da) 1977-04-18
SE405254B (sv) 1978-11-27
NO140824C (no) 1979-11-21
CS205010B2 (en) 1981-04-30
FR2287908A1 (fr) 1976-05-14
CH619268A5 (xx) 1980-09-15
FI752836A (xx) 1976-04-15
CA1054143A (en) 1979-05-08
ES441784A1 (es) 1977-04-01
YU294281A (en) 1982-06-30
FR2287908B1 (xx) 1980-04-30
ATA775475A (de) 1978-07-15
YU243975A (en) 1982-06-30
FI54603B (fi) 1978-09-29
SE7511438L (sv) 1976-04-15
NO753455L (xx) 1976-04-20
DK439975A (da) 1976-04-15
US4011314A (en) 1977-03-08
SU677666A1 (ru) 1981-11-30
GB1528796A (en) 1978-10-18
FI54603C (fi) 1979-01-10
NO140824B (no) 1979-08-13
NL7512041A (nl) 1976-04-20
SU677666A3 (en) 1981-11-30
DD125588A5 (xx) 1977-05-04
IE42167L (en) 1976-04-14
DK135378C (da) 1977-10-03
JPS5165747A (en) 1976-06-07
IL48276A0 (en) 1975-12-31

Similar Documents

Publication Publication Date Title
CH619240A5 (xx)
DE1543273C3 (de) 7 alpha-Methyl-Delta hoch 5(16) -steroide der Oestranreihe und Verfahren zu deren Herstellung
EP0372665A1 (de) 14alpha, 17alpha-Ethano-estratriene
CH618182A5 (xx)
DE1468410A1 (de) Verfahren zur Herstellung von 16-Methylensteroiden
DD266801A5 (de) Verfahren zur herstellung einer oestrogen wirksamen verbindung
DE1568307A1 (de) Verfahren zur Herstellung neuer 19-Norandrostatriene
CH618181A5 (xx)
DE1493042B2 (de) 17 Tetrahydropyranylather und 3,17 Bis (tetrahydropyranyl)-ather von Östradiol und Ostradioldenvaten, Ver fahren zu deren Herstellung und diese enthaltende Heilmittel
DE2449327C2 (de) 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE1296632B (de) Verfahren zur Herstellung von 3-Oxo-13ª‰-alkyl-17ª‰-hydroxy-17ª‡-aethinylgona-5(10), 9(11)-dienen
DE1593509C3 (de) 1-Hydroxy-7alpha-methyl-östradlol-Derivate, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE2207421C3 (de) 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1643005C3 (de) 15,16beta-Methylen-testosterone, Verfahren zu ihrer Herstellung sowie diese Steroide enthaltende Mittel
DE2715775A1 (de) Neue d-homosteroide
DE2004313A1 (de) 3-Desoxo-19-nor-steroidverbindungen und Verfahren zu ihrer Herstellung
DE2118995A1 (de) Neue oestrogen hochwirksame Steroide und ein Verfahren zu deren Herstellung
DE1593444C3 (de) In 17-Stellung substituierte 3-Methoxy-I1 beta-methyl-östra-1,3,5(10)-triene und Verfahren zu ihrer Herstellung
DE1493108C (de) Steroidverbindungen
DE2001262A1 (de) 19-Homosteroide
DE1144270B (de) Verfahren zur Herstellung neuer anabolisch und progestativ wirkender ?-3-Keto-6-methyl-19-norsteroide
DE1084261B (de) Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate
DE2426777A1 (de) 1.3-oxygenierte 8 alpha-oestratriene
CH606094A5 (en) 18,18-Difluoro steroids prepn. with hormonal activity
CH391696A (de) Verfahren zur Herstellung von 6-Methyl-19-norsteroiden

Legal Events

Date Code Title Description
PL Patent ceased